International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(11), P. 6068 - 6068
Published: May 31, 2024
Psoriasis
is
a
chronic
autoimmune
inflammatory
skin
disorder
that
affects
approximately
2–3%
of
the
global
population
due
to
significant
genetic
predisposition.
It
characterized
by
an
uncontrolled
growth
and
differentiation
keratinocytes,
leading
formation
scaly
erythematous
plaques.
extends
beyond
dermatological
manifestations
impact
joints
nails
often
associated
with
systemic
disorders.
Although
traditional
treatments
provide
relief,
their
use
limited
potential
side
effects
nature
disease.
This
review
aims
discuss
therapeutic
keratinocyte-targeting
natural
products
in
psoriasis
highlight
efficacy
safety
comparison
conventional
treatments.
comprehensively
examines
pathogenesis
within
keratinocytes
various
related
signaling
pathways
(such
as
JAK-STAT
NF-κB)
cytokines.
presents
molecular
targets
such
high-mobility
group
box-1
(HMGB1),
dual-specificity
phosphatase-1
(DUSP1),
aryl
hydrocarbon
receptor
(AhR)
for
treating
psoriasis.
evaluates
ability
compounds
luteolin,
piperine,
glycyrrhizin
modulate
psoriasis-related
pathways.
Finally,
it
offers
insights
into
alternative
sustainable
treatment
options
fewer
effects.
Science Translational Medicine,
Journal Year:
2024,
Volume and Issue:
16(735)
Published: Feb. 21, 2024
Acute
graft-versus-host
disease
(aGVHD)
is
a
life-threatening
complication
of
allogeneic
hematopoietic
cell
transplantation
(allo-HCT),
for
which
therapeutic
options
are
limited.
Strategies
to
promote
intestinal
tissue
tolerance
during
aGVHD
may
improve
patient
outcomes.
Using
single-cell
RNA
sequencing,
we
identified
lipocalin-2
(LCN2)–expressing
neutrophil
population
in
mice
with
aGVHD.
Transfer
LCN2-overexpressing
neutrophils
or
treatment
recombinant
LCN2
reduced
severity,
whereas
the
lack
epithelial
enhanced
severity
and
caused
microbiome
alterations.
Mechanistically,
induced
insulin-like
growth
factor
1
receptor
(IGF-1R)
signaling
macrophages
through
SLC22A17,
increased
interleukin-10
(IL-10)
production
major
histocompatibility
complex
class
II
(MHCII)
expression.
LCN2-pretreated
but
did
not
reduce
graft-versus-leukemia
effects.
Furthermore,
expression
correlated
IL-10
biopsies
multiple
cohorts
patients
aGVHD,
IGF-1R
human
macrophages.
Collectively,
LCN2-expressing
that
by
decreasing
MHCII
increasing
This
work
provides
foundation
administration
as
approach
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
14
Published: Jan. 4, 2024
Psoriasis
is
a
chronic
autoimmune
inflammatory
disease
characterized
by
erroneous
metabolism
of
keratinocytes.
The
development
psoriasis
closely
related
to
abnormal
activation
and
disorders
the
immune
system.
Dysregulated
skin
protective
mechanisms
can
activate
pathways
within
epithelial
microenvironment
(EIME),
leading
autoimmune-related
diseases.
In
this
review,
we
initially
emphasized
pathogenesis
psoriasis,
paying
particular
attention
interactions
between
cells
production
cytokines
in
psoriasis.
Subsequently,
delved
into
significance
EIME
emergence
A
thorough
understanding
these
processes
crucial
targeted
therapies
for
Finally,
discussed
potential
novel
aimed
at
modulating
This
comprehensive
examination
sheds
light
on
intricate
underlying
provides
insights
therapeutic
avenues
immune-mediated
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(9), P. 4681 - 4681
Published: April 25, 2024
Psoriasis
is
a
highly
prevalent
dermatological
disease
associated
with
an
increased
systemic
inflammatory
response.
In
addition,
joint
involvement
also
present
in
around
20%
of
patients.
Therefore,
treatment
modalities
used
this
condition
should
be
simultaneously
effective
at
improving
skin
manifestations,
reducing
inflammation,
and
addressing
psoriatic
arthritis
when
present.
Twenty
years
ago,
the
introduction
biologic
treatments
for
psoriasis
was
turning
point
management
condition,
offering
reasonably
safe
option
patients
whose
could
not
adequately
controlled
conventional
therapies.
At
moment,
Janus
Kinase
inhibitors
(JAKis)
are
new
class
promising
molecules
psoriasis.
They
orally
administered
can
show
benefits
who
failed
therapy.
We
conducted
scoping
review
order
to
identify
randomized-controlled
trials
that
investigated
different
JAKis
plaque
arthritis,
emphasis
on
have
been
approved
by
European
Medicines
Agency
Food
Drug
Administration.
The
added
value
study
it
collected
information
about
two
indications,
provide
integrated
understanding
range
effects
whole
spectrum
manifestations.
Journal of Personalized Medicine,
Journal Year:
2024,
Volume and Issue:
14(5), P. 535 - 535
Published: May 16, 2024
Psoriasis
is
a
chronic
recurrent
inflammatory
autoimmune
pathology
with
significant
genetic
component
and
several
interferences
of
immunological
cells
their
cytokines.
The
complex
orchestration
psoriasis
pathogenesis
related
to
the
synergic
effect
immune
cells,
polygenic
alterations,
autoantigens,
other
external
factors.
major
act
IL-23/IL-17
axis,
strongly
influencing
pattern
established
during
disease
activity,
visible
as
continuous
perpetuation
pro-inflammatory
response
keratinocyte
activation
proliferation,
leading
development
psoriatic
lesions.
Genome-wide
association
studies
(GWASs)
offer
better
view
pathogenic
pathways,
approximately
one-third
psoriasis’s
impact
on
associated
MHC
region,
loci
located
chromosome
6.
most
eloquent
factor
psoriasis,
PSORS1,
was
identified
in
I
site.
Among
factors
involved
its
etiology,
dysbiosis,
due
or
stimulus,
induces
burst
consequences;
both
cutaneous
gut
microbiome
get
process.
Cutting-edge
research
comprehensive
insights
into
pathogenesis,
fostering
novel
genetic,
epigenetic,
factors,
have
generated
spectacular
improvement
over
past
decades,
securing
path
toward
specific
targeted
immunotherapeutic
approach
delayed
progression
arthritis.
This
review
aimed
insight
various
domains
that
underline
how
they
influence
evolution.
mechanism
multifaceted
involves
an
interplay
cellular
humoral
immunity,
which
affects
susceptible
microbiota
background.
An
in-depth
understanding
role
forms
basis
for
developing
individualized
therapeutic
targets
can
improve
management.
FEBS Open Bio,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 17, 2025
Dimethyl
fumarate
(DMF)
is
an
anti‐inflammatory
and
immunoregulatory
medication
used
to
treat
multiple
sclerosis
(MS)
psoriasis.
Its
skin
sensitization
property
precludes
its
topical
use,
which
unfortunate
for
the
treatment
of
Isosorbide
di‐(methyl
fumarate)
(IDMF),
a
novel
derivative
DMF,
was
synthesized
circumvent
this
adverse
reaction
unlock
potential
delivery,
could
be
useful
treating
psoriasis
in
subpopulation
psoriatic
MS
patients,
as
well
general
population.
Here,
we
compared
therapeutic
non‐sensitizing
with
DMF
version
Diroximel
three
skin‐
neuroinflammation
models:
lck‐GFP
zebrafish,
activated
BV‐2
murine
microglia
human
T‐lymphocyte
Jurkat
cell
line.
The
results
provide
comparative
evaluation
bioactivity
these
related
chemical
entities
models
relevant
expose
several
advantages
unique
IDMF.
Cell Death and Disease,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: Jan. 22, 2025
Abstract
Arachidonate
15-lipoxygenase
type
B
(ALOX15B)
peroxidises
polyunsaturated
fatty
acids
to
their
corresponding
acid
hydroperoxides,
which
are
subsequently
reduced
into
hydroxy-fatty
acids.
A
dysregulated
abundance
of
these
biological
lipid
mediators
has
been
reported
in
the
skin
and
blood
psoriatic
compared
healthy
individuals.
RNAscope
immunohistochemistry
revealed
increased
ALOX15B
expression
lesional
psoriasis
samples.
Using
a
cytokine
cocktail
containing
IL-17A,
interferon-gamma
tumour
necrosis
factor-alpha
produce
psoriasis-like
phenotype,
role
for
human
epidermal
keratinocyte
inflammation
was
investigated.
siRNA-mediated
silencing
CCL2
secretion.
In
addition
CCL2,
secretion
CCL5
CXCL10
were
elevated
equivalents
treated
with
lipoxygenase
inhibitor
ML351.
Inhibition
JAK1/STAT1
pathway
reversed
enhanced
found
silencing.
Previous
studies
have
linked
growth
factor
receptor
(EGFR)
inhibition
upregulation
cytokines
including
CXCL10.
EGFR
signalling
potentiated
effect
on
expression.
Confirming
previous
findings,
gene
cholesterol
biosynthesis
genes
via
ERK
phosphorylation.
Reduced
phosphorylation
dependant
NRF2
activation.
Furthermore,
plasma
membrane
lipids
investigated
confocal
microscopy,
revealing
rafts.
This
study
suggests
through
modulation
peroxidation
EGFR/JAK1/STAT1
axis.
Frontiers in Medicine,
Journal Year:
2025,
Volume and Issue:
11
Published: Jan. 24, 2025
This
case
report
presents
an
instance
of
Tumor
Necrosis
Factor-
α
Inhibitor-induced
psoriasis
(TNFiIP),
also
known
as
paradoxical
psoriasis,
in
a
30-year-old
male
with
fistulizing
Crohn’s
disease.
The
patient
developed
extensive
erythematous
and
scaly
lesions
on
the
palms,
lower
limbs,
ankles,
soles
after
4
months
adalimumab
monotherapy.
Histopathological
analysis
revealed
pattern
psoriasiform
dermatitis
notable
dermal
neutrophil
eosinophil
infiltration,
distinguishing
TNFiIP
from
idiopathic
psoriasis.
patient’s
condition
significantly
improved
following
transition
to
ustekinumab,
which
highlights
importance
alternative
therapeutic
strategies
for
patients
who
exhibit
reactions
TNF-
inhibitors.
Dermatology Practical & Conceptual,
Journal Year:
2025,
Volume and Issue:
15(1), P. 4458 - 4458
Published: Jan. 29, 2025
Introduction:
Psoriasis
and
bullous
pemphigoid
(BP)
are
the
2
major
types
of
immune-mediated
inflammatory
skin
diseases.
Studies
have
reported
association
between
psoriasis
BP;
however,
no
studies
whether
a
causal
relationship
exists
these
Objectives:
In
order
to
explore
BP,
we
performed
bidirectional
two-sample
Mendelian
randomization
(MR)
study.
Methods:
Genome-wide
study
(GWAS)
data
related
BP
were
collected.
The
inverse
variance
weighted
(IVW)
method
was
primarily
applied
for
our
MR
analysis,
MR-Egger,
median,
simple
mode,
mode
methods
used
additionally.
Heterogeneity,
horizontal
pleiotropy,
potential
outliers
assessed
analysis
results.
Results:
GWAS
(3
cohorts)
(1
cohort)
from
publicly
available
trials
selected.
Our
results
showed
that
causally
associated
with
could
increase
risk
reversed
has
effect
on
psoriasis.
No
heterogeneity
or
pleiotropy
detected.
Conclusion:
These
findings
provided
new
evidence
suggested
is
potentially
which
help
us
improving
treatment
strategy
patients
mechanism
remains
open
further
investigation.
Journal of Translational Medicine,
Journal Year:
2025,
Volume and Issue:
23(1)
Published: Feb. 4, 2025
Rheumatoid
arthritis
(RA)
and
Psoriatic
(PsA)
are
chronic
inflammatory
diseases
mainly
affecting
joints.
RA
primarily
targets
the
synovial
joints
is
characterized
by
cartilage
bone
erosion,
whereas
PsA
associated
with
skin
nail
psoriasis
erosive
damage
an
exuberant
formation
soft
tissue
involvement.
Recent
evidence
described
involvement
of
Wnt
pathway
in
pathogenesis
these
diseases.
Thus,
we
aimed
to
analyze
some
components
signaling,
i.e.
DKK1,
5a
β-catenin,
their
association
disease
activity
indices,
investigating
possible
differences
between
two
Sera
from
18
patients
naïve
for
biological
therapy,
20
matched
healthy
donors
(HD)
were
tested
DKK1
ELISA,
β-catenin
Immunoblotting.
Values
correlated
CTX-1,
detected
indices:
Disease
Activity
Score
on
28
(DAS28-CRP)
Arthritis
(DAPSA)
score
PsA.
This
study
highlights
significant
increase
5a,
levels
compared
HD,
distinct
patterns
correlation
indices.
Indeed,
patients,
positively
DAS28-CRP
score,
negatively
DAPSA
score.
Our
findings
showed
a
strong
CTX-1
supporting
relationship
presence
joint
erosions.
Furthermore,
positive
was
found
IL-6
RA,
indicating
that
may
be
involved
cascade.
compares
signaling
PsA,
suggesting
represent
mechanism
activity.
In
particular,
it
indicates
marker
resorption,
patients.
These
underscore
importance
biomarkers
potential
monitoring
offering
insights
into
mechanisms
therapeutic
targets.